Cargando…

SPDL1 Is an Independent Predictor of Patient Outcome in Colorectal Cancer

Spindle Apparatus Coiled-Coil Protein 1 (SPDL1) is a relatively recently identified coiled-coil domain containing protein and an important determinant of DNA fidelity by ensuring faithful mitosis. Hence, SPDL1 is suspected to underlie genomic (in-)stability in human cancers, yet its exact roles in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Klimaszewska-Wiśniewska, Anna, Buchholz, Karolina, Durślewicz, Justyna, Villodre, Emilly Schlee, Gagat, Maciej, Grzanka, Dariusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836361/
https://www.ncbi.nlm.nih.gov/pubmed/35163739
http://dx.doi.org/10.3390/ijms23031819
_version_ 1784649659517501440
author Klimaszewska-Wiśniewska, Anna
Buchholz, Karolina
Durślewicz, Justyna
Villodre, Emilly Schlee
Gagat, Maciej
Grzanka, Dariusz
author_facet Klimaszewska-Wiśniewska, Anna
Buchholz, Karolina
Durślewicz, Justyna
Villodre, Emilly Schlee
Gagat, Maciej
Grzanka, Dariusz
author_sort Klimaszewska-Wiśniewska, Anna
collection PubMed
description Spindle Apparatus Coiled-Coil Protein 1 (SPDL1) is a relatively recently identified coiled-coil domain containing protein and an important determinant of DNA fidelity by ensuring faithful mitosis. Hence, SPDL1 is suspected to underlie genomic (in-)stability in human cancers, yet its exact roles in these diseases remain largely underexplored. Given that genomic instability (GIN) is a crucial feature in colorectal cancer (CRC), we primarily asked whether the expression of this protein may account for differences in clinicopathological features and survival rates of CRC patients. Protein expression was evaluated by immunohistochemistry in the institutional tissue microarray (TMA), and gene expression by the analysis of publicly available datasets. To place the prognostic relevance in a predicted biological context, gene co-expression set around SPDL1 identified by public data mining was annotated and assessed for enrichment in gene ontology (GO) categories, BRITE hierarchies, and Reactome pathways. The comparison with adjacent normal tissue revealed a high expression of SPDL1 protein in a subset of tumor cases (48.84%), and these had better prognosis than the SPDL1-low expression counterpart even after adjustment for multiple confounders. SPDL1-high expression within tumors was associated with a median 56-month survival advantage, but not with any clinicopathological characteristics of our cohort. In the TCGA cohort, SPDL1 was overexpressed in tumor tissue and positively associated with improved survival, chromosome instability phenotype, and various GIN markers. In addition to the genes critically involved in the cell cycle and mitosis, a gene set co-expressed with SPDL1 contained checkpoint members of both chromosome segregation and DNA replication, as well as those associated with defective DNA repair, and retrograde vesicle-mediated transport. In conclusion, SPDL1 is an independent predictor of CRC patient survival in a possible connection with chromosomal instability.
format Online
Article
Text
id pubmed-8836361
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88363612022-02-12 SPDL1 Is an Independent Predictor of Patient Outcome in Colorectal Cancer Klimaszewska-Wiśniewska, Anna Buchholz, Karolina Durślewicz, Justyna Villodre, Emilly Schlee Gagat, Maciej Grzanka, Dariusz Int J Mol Sci Article Spindle Apparatus Coiled-Coil Protein 1 (SPDL1) is a relatively recently identified coiled-coil domain containing protein and an important determinant of DNA fidelity by ensuring faithful mitosis. Hence, SPDL1 is suspected to underlie genomic (in-)stability in human cancers, yet its exact roles in these diseases remain largely underexplored. Given that genomic instability (GIN) is a crucial feature in colorectal cancer (CRC), we primarily asked whether the expression of this protein may account for differences in clinicopathological features and survival rates of CRC patients. Protein expression was evaluated by immunohistochemistry in the institutional tissue microarray (TMA), and gene expression by the analysis of publicly available datasets. To place the prognostic relevance in a predicted biological context, gene co-expression set around SPDL1 identified by public data mining was annotated and assessed for enrichment in gene ontology (GO) categories, BRITE hierarchies, and Reactome pathways. The comparison with adjacent normal tissue revealed a high expression of SPDL1 protein in a subset of tumor cases (48.84%), and these had better prognosis than the SPDL1-low expression counterpart even after adjustment for multiple confounders. SPDL1-high expression within tumors was associated with a median 56-month survival advantage, but not with any clinicopathological characteristics of our cohort. In the TCGA cohort, SPDL1 was overexpressed in tumor tissue and positively associated with improved survival, chromosome instability phenotype, and various GIN markers. In addition to the genes critically involved in the cell cycle and mitosis, a gene set co-expressed with SPDL1 contained checkpoint members of both chromosome segregation and DNA replication, as well as those associated with defective DNA repair, and retrograde vesicle-mediated transport. In conclusion, SPDL1 is an independent predictor of CRC patient survival in a possible connection with chromosomal instability. MDPI 2022-02-05 /pmc/articles/PMC8836361/ /pubmed/35163739 http://dx.doi.org/10.3390/ijms23031819 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Klimaszewska-Wiśniewska, Anna
Buchholz, Karolina
Durślewicz, Justyna
Villodre, Emilly Schlee
Gagat, Maciej
Grzanka, Dariusz
SPDL1 Is an Independent Predictor of Patient Outcome in Colorectal Cancer
title SPDL1 Is an Independent Predictor of Patient Outcome in Colorectal Cancer
title_full SPDL1 Is an Independent Predictor of Patient Outcome in Colorectal Cancer
title_fullStr SPDL1 Is an Independent Predictor of Patient Outcome in Colorectal Cancer
title_full_unstemmed SPDL1 Is an Independent Predictor of Patient Outcome in Colorectal Cancer
title_short SPDL1 Is an Independent Predictor of Patient Outcome in Colorectal Cancer
title_sort spdl1 is an independent predictor of patient outcome in colorectal cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836361/
https://www.ncbi.nlm.nih.gov/pubmed/35163739
http://dx.doi.org/10.3390/ijms23031819
work_keys_str_mv AT klimaszewskawisniewskaanna spdl1isanindependentpredictorofpatientoutcomeincolorectalcancer
AT buchholzkarolina spdl1isanindependentpredictorofpatientoutcomeincolorectalcancer
AT durslewiczjustyna spdl1isanindependentpredictorofpatientoutcomeincolorectalcancer
AT villodreemillyschlee spdl1isanindependentpredictorofpatientoutcomeincolorectalcancer
AT gagatmaciej spdl1isanindependentpredictorofpatientoutcomeincolorectalcancer
AT grzankadariusz spdl1isanindependentpredictorofpatientoutcomeincolorectalcancer